# SSG (CHINA) · 99-39 · CHINA — FDA import alert red lists: firms subject to detention without physical examination

For SSG (CHINA) · 99-39 · CHINA, import alert is 99-39; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; country is CHINA; product is Life Minerals Liquid; product code is 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 08/14/2017; address is Beijing News Plaza 5th Floor , No. 26 Jianguomen Nei Da Jie , Beijing, Beijing CHINA, verified against its source on 2026-09-16.

- **Firm:** SSG (CHINA) _(verified: appears in the quote below)_
- **Import alert:** 99-39
- **Import alert name:** Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
- **Country:** CHINA _(verified: appears in the quote below)_
- **Address:** Beijing News Plaza 5th Floor , No. 26 Jianguomen Nei Da Jie , Beijing, Beijing CHINA _(verified: appears in the quote below)_
- **Date published:** 08/14/2017 _(verified: appears in the quote below)_
- **Product code:** 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 66 V - - 99 Miscellaneous Patent Medicines, Etc. _(verified: each item appears in the quote below)_
- **Product:** Life Minerals Liquid _(verified: appears in the quote below)_
- **FDA notes:** Life Minerals Liquid; Section 403(s)(2)(B) of the Act in that the label of the dietary supplement fails to identify the product by using the term "dietary supplement" in accordance with 21 CFR 101.3(g). Section 403(a)(1) of the Act in that the label is false and misleading in any particular. Section 403(q)(5)(F) of the Act in that the presentation of the nutrition information on the labeling of the product does not comply with 21 CFR 101.36. Section 403(r)(1)(A) of the Act because the product label bears a nutrient content claim, but fails to meet the requirements to bear the claim. Section 403(i)(2) of the Act [21 U.S.C.§343(i)(2)], in that it is fabricated from two or more ingredients but, the product label fails to declare the source ingredient for the listed dietary ingredients as required by 21CFR 101.4(a)(1) and (g). Section 403(f) of the Act [21 U.S.C. 343(f)] in that the product label contains information in two languages but does not repeat all the required label information in both languages as required by 21CFR 101.15(c). | Section 403(s)(2)(B) of the Act in that the label of the dietary supplement fails to identify the product by using the term "dietary supplement" in accordance with 21 CFR 101.3(g). Section 403(a)(1) of the Act in that the label is false and misleading in any particular. Section 403(q)(5)(F) of the Act in that the presentation of the nutrition information on the labeling of the product does not comply with 21 CFR 101.36. Section 403(r)(1)(A) of the Act because the product label bears a nutrient content claim, but fails to meet the requirements to bear the claim. Section 403(i)(2) of the Act [21 U.S.C.§343(i)(2)], in that it is fabricated from two or more ingredients but, the product label fails to declare the source ingredient for the listed dietary ingredients as required by 21CFR 101.4(a)(1) and (g). Section 403(f) of the Act [21 U.S.C. 343(f)] in that the product label contains information in two languages but does not repeat all the required label information in both languages as required by 21CFR 101.15(c). _(verified: each item appears in the quote below)_

## What the source says

> SSG (CHINA) Date Published : 08/14/2017 Beijing News Plaza 5th Floor , No. 26 Jianguomen Nei Da Jie , Beijing, Beijing CHINA 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) Date Published: 08/14/2017 Notes: Life Minerals Liquid; Section 403(s)(2)(B) of the Act in that the label of the dietary supplement fails to identify the product by using the term "dietary supplement" in accordance with 21 CFR 101.3(g). Section 403(a)(1) of the Act in that the label is false and misleading in any particular. Section 403(q)(5)(F) of the Act in that the presentation of the nutrition information on the labeling of the product does not comply with 21 CFR 101.36. Section 403(r)(1)(A) of the Act because the product label bears a nutrient content claim, but fails to meet the requirements to bear the claim. Section 403(i)(2) of the Act [21 U.S.C.§343(i)(2)], in that it is fabricated from two or more ingredients but, the product label fails to declare the source ingredient for the listed dietary ingredients as required by 21CFR 101.4(a)(1) and (g). Section 403(f) of the Act [21 U.S.C. 343(f)] in that the product label contains information in two languages but does not repeat all the required label information in both languages as required by 21CFR 101.15(c). 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 08/14/2017 Desc: Life Minerals Liquid Notes: Section 403(s)(2)(B) of the Act in that the label of the dietary supplement fails to identify the product by using the term "dietary supplement" in accordance with 21 CFR 101.3(g). Section 403(a)(1) of the Act in that the label is false and misleading in any particular. Section 403(q)(5)(F) of the Act in that the presentation of the nutrition information on the labeling of the product does not comply with 21 CFR 101.36. Section 403(r)(1)(A) of the Act because the product label bears a nutrient content claim, but fails to meet the requirements to bear the claim. Section 403(i)(2) of the Act [21 U.S.C.§343(i)(2)], in that it is fabricated from two or more ingredients but, the product label fails to declare the source ingredient for the listed dietary ingredients as required by 21CFR 101.4(a)(1) and (g). Section 403(f) of the Act [21 U.S.C. 343(f)] in that the product label contains information in two languages but does not repeat all the required label information in both languages as required by 21CFR 101.15(c).

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_1144.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).